Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover
BRIEF-Guard Therapeutics Enters Conditional Deal For Reverse Takeover June 11 (Reuters) - Guard Therapeutics International AB (publ) GUARD.ST:
SAID ON WEDNESDAY IT ENTERED INTO A CONDITIONAL AGREEMENT FOR A REVERSE TAKEOVER WITH DISRUPTIVE PHARMA
ACQUISITION IS INTENDED TO BE CARRIED OUT THROUGH A ISSUE-IN-KIND
DISRUPTIVE PHARMA WILL BECOME A SUBSIDIARY OF GUARD THERAPEUTICS
AS A RESULT OF THE TRANSACTION, CO WILL CHANGE ITS CORPORATE NAME TO DISRUPTIVE PHARMA
SUBSCRIPTION PRICE OF APPROXIMATELY SEK 2.48 PER CONSIDERATION SHARE
TRANSACTION REGARDING GTX PLATFORM WITH THIRD PARTY, WHICH MAY INCLUDE TRANSFER, OUT-LICENSING, OR OTHER ARRANGEMENT, WOULD BE APPROPRIATE
Source text for Workspace: nMFN5nDCHC
Further company coverage: GUARD.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover